N/A
N=76
Thrombolytic Care During Inter-hospital Transfer
Stroke
Bottom Line
View on ClinicalTrials.gov: NCT02752256 ↗Enrolled (actual)
76
Serious AEs
0.0%
Results posted
Jul 2019
Primary outcome: Primary: Percentage of Participants With a rtPA Protocol Violation — 7; 0 Participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Tissue Plasminogen Activator (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Iowa
- Primary completion
- Oct 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Participants With a rtPA Protocol Violation |
7; 0 | — |
| SECONDARY Average Time to rtPA |
74.5; 60 | — |
Summary
Evaluation of ischemic stroke patients receiving tissue plasminogen activator (rtPA) during air ambulance transfer
Eligibility Criteria
Inclusion Criteria
- Patients who received tissue plasminogen activator for acute ischemic stroke
- presented directly to comprehensive stroke center or were transferred by our air ambulance service
Exclusion Criteria
- Transferred by another air ambulance service or ground ambulance
Data sourced from ClinicalTrials.gov (NCT02752256). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.